Lipocine Investor Relations Material
Latest events
Status Update
Lipocine
Q1 2025
20 Aug, 2025
Q2 2025
5 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Lipocine Inc
Access all reports
Lipocine Inc. is a biopharmaceutical company focused on the development of oral drug delivery technologies for treating metabolic and endocrine disorders. The company specializes in hormone therapeutics, leveraging its proprietary Liprocol technology to enhance drug absorption and bioavailability. Lipocine's pipeline includes treatments for conditions such as testosterone deficiency, liver disease, and neuroendocrine disorders. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
)
)
)